Novophage Completes $5.7M Series A Financing
Novophage, a Boston, MA-based early-stage technology company that develops a new class of biologics for different industrial applications, has completed a $5.7m Series A round of financing. The round was led by Flybridge Capital Partners, with participation from Founder Collective, Boston University (BU) and strategic investors Chevron Technology Ventures and The Kraft Group. In conjunction […]